Nigeria has approved a new malaria vaccine developed by scientists at Oxford University.
The move comes days after Ghana became the first country in the world to approve the (R21) vaccine.
The head of Nigeria’s National Agency for Food and Drugs Administration, Mojisola Adeyeye, said the vaccine would be used for prevention of malaria in children aged between five months and three years – the most vulnerable group.
The approval is unusual as it comes before the publication of final stage trial data for the vaccine, which is thought to be 80% effective.
Nigeria has the highest number of malaria deaths worldwide.
The disease kills more than 6,000 people around the world every year – many of them children in Sub-Saharan Africa.
THANK YOU for constantly reading our stories. Kindly like, comment and SHARE stories on all social media platforms for more entertaining updates!
TO GET YOUR EXCLUSIVE INFO PUBLISHED ONLINE?
Call or WhatsApp our Editor on +233208291107/0546509004 for Your Massive promo. You can equally email your stories or articles to info@xpressghonline.com or fuzzygh2016@gmail.com and we’ll surely put them online at www.xpressghonline.com or www.smartghonline.com